Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 May 1;181(5):1653-9.
doi: 10.1084/jem.181.5.1653.

Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes

Affiliations

Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes

T Brocker et al. J Exp Med. .

Abstract

Activation studies performed with transfected T cell hybridomas and tumors revealed that chimeric molecules containing the CD3 epsilon or zeta chain intracytoplasmic portions can induce the complete effector functions normally seen only when the complete T cell receptor (TCR)/CD3 complexes of T lymphocytes are triggered. Therefore, the zeta chain, with its three antigen recognition activation motives, is thought to connect the antigen-binding Ti chains with the intracellular signaling machinery of the T cell. Here we demonstrate that the cytoplasmic portion of the TCR-zeta chain is not sufficient to activate resting T lymphocytes when cells from transgenic mice expressing a chimeric zeta receptor are used. However, after (in vivo and in vitro) activation through their endogenous TCR/CD3 complexes, the preactivated T lymphocytes could be triggered through the zeta chimera to the same extent as when they were activated through their endogenous TCR/CD3 complexes. They were able to proliferate and elicit cytotoxic functions when triggered through their zeta chimeras. These results suggest that the triggering requirements for effector functions seem to be different in resting than in activated T cells.

PubMed Disclaimer

References

    1. J Immunol. 1981 Dec;127(6):2262-8 - PubMed
    1. Cell. 1994 Jan 28;76(2):263-74 - PubMed
    1. Nature. 1986 Feb 27-Mar 5;319(6056):778-80 - PubMed
    1. Cell. 1986 Jun 6;45(5):685-98 - PubMed
    1. Nature. 1986 May 22-28;321(6068):431-4 - PubMed

Publication types

Substances